Arrow Financial Corp Eli Lilly & CO Transaction History

Arrow Financial Corp

$1.07 Billion
Q3 2024

A detailed history of Arrow Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Arrow Financial Corp holds 8,726 shares of LLY stock, worth $6.51 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

8,726

Previous 8,729 0.03%

Holding current value

$6.51 Million

Previous $7.9 Million 2.19%

% of portfolio

0.73%

Previous 0.78%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$772.14 - $960.02 $2,316 - $2,880	-3 Reduced 0.03%	8,726 $7.73 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $116,704 - $146,355	161 Added 1.88%	8,729 $7.9 Million
Q1 2024 May 21, 2024	BUY	$592.2 - $792.28 $505,146 - $675,814	853 Added 11.06%	8,568 $6.67 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $1.03 Million - $1.22 Million	1,966 Added 34.2%	7,715 $4.5 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $1.05 Million - $1.44 Million	2,405 Added 71.92%	5,749 $3.09 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $387,216 - $517,753	1,104 Added 49.29%	3,344 $1.57 Million
Q4 2022 Feb 01, 2023	SELL	$321.55 - $374.67 $11,254 - $13,113	-35 Reduced 1.54%	2,240 $820,000
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $14,824 - $16,893	-50 Reduced 2.15%	2,275 $736,000
Q2 2022 Jul 25, 2022	SELL	$278.73 - $327.27 $141,594 - $166,253	-508 Reduced 17.93%	2,325 $754,000
Q4 2021 Jan 28, 2022	SELL	$224.85 - $279.04 $11,692 - $14,510	-52 Reduced 1.8%	2,833 $782,000
Q3 2021 Oct 21, 2021	SELL	$221.6 - $272.71 $7,756 - $9,544	-35 Reduced 1.2%	2,885 $667,000
Q2 2021 Jul 21, 2021	SELL	$180.55 - $233.54 $14,444 - $18,683	-80 Reduced 2.67%	2,920 $670,000
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $27,112 - $35,098	-165 Reduced 5.21%	3,000 $561,000
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $14,622 - $16,913	-100 Reduced 3.06%	3,165 $468,000
Q2 2020 Jul 27, 2020	SELL	$136.42 - $164.18 $9,549 - $11,492	-70 Reduced 2.1%	3,265 $536,000
Q1 2020 Apr 21, 2020	SELL	$119.05 - $147.35 $17,857 - $22,102	-150 Reduced 4.3%	3,335 $462,000
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $198,871 - $246,319	-1,860 Reduced 34.8%	3,485 $458,000
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $232,268 - $252,648	-2,175 Reduced 28.92%	5,345 $598,000
Q1 2019 Apr 26, 2019	BUY	$111.31 - $131.02 $229,632 - $270,294	2,063 Added 37.8%	7,520 $975,000
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $13,555 - $15,185	-128 Reduced 2.29%	5,457 $632,000
Q3 2018 Oct 11, 2018	BUY	$85.86 - $107.31 $3,434 - $4,292	40 Added 0.72%	5,585 $599,000
Q2 2018 Jul 30, 2018	BUY	$75.7 - $86.88 $3,028 - $3,475	40 Added 0.73%	5,545 $474,000
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $424,270 - $470,897	5,505	5,505 $471,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Financial Corp with notifications on news.

Account

Arrow Financial Corp Eli Lilly & CO Transaction History